EP Biocomposites
Close ·
Key Fundamentals
SMEOther UtilitiesUtilitiesPrice-based figures at the close · TTM
- ROCE
- 16.30%
- Debt to Equity
- 0.20
- EPS (TTM)
- —
- Book Value
- ₹71.68
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 1.23
- ROE
- 12.90%
- Dividend Yield
- 0.00%
- EBITDA
- ₹2.40 Cr
- 52W High
- ₹119.60
- 52W Low
- ₹75.50
Key Insights
No strengths listed
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.0% over last 3 years.
- Company has high debtors of 317 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 6 | 1 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 45.59
- Neutral
- MACD (12,26,9)
- −2.72
- Bearish
- SMA (50)
- 96.86
- Bearish
- SMA (200)
- 108.16
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +35.83% |
|---|---|
| 3Y | +24.20% |
| 1Y | +13.57% |
Net profit
| 5Y | +32.32% |
|---|---|
| 3Y | +36.03% |
| 1Y | +41.75% |
Operating cash flow
| 5Y | +131.39% |
|---|---|
| 3Y | Turned positive |
| 1Y | Turned positive |
Operating margin· change in pp
| 5Y | +0.83 pp |
|---|---|
| 3Y | +2.80 pp |
| 1Y | +1.60 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2021 | ₹2.95 Cr |
|---|---|
| Mar 2022 | ₹8.06 Cr |
| Mar 2023 | ₹7.12 Cr |
| Mar 2024 | ₹11.43 Cr |
| Mar 2025 | ₹12.01 Cr |
| Mar 2026 | ₹13.64 Cr |
Net profit by year
| Mar 2021 | ₹0.36 Cr |
|---|---|
| Mar 2022 | ₹0.81 Cr |
| Mar 2023 | ₹0.58 Cr |
| Mar 2024 | ₹1.15 Cr |
| Mar 2025 | ₹1.03 Cr |
| Mar 2026 | ₹1.46 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.76 | 5.3 | 3.45 | 3.68 | 4.4 | 7.04 | 4.4 | 7.6 | 4.07 | 9.57 |
| Expenses | 2.42 | 4.27 | 2.92 | 3.26 | 4.14 | 5.9 | 3.91 | 6.31 | 3.82 | 7.58 |
| Operating Profit | 0.34 | 1.03 | 0.53 | 0.42 | 0.26 | 1.14 | 0.49 | 1.29 | 0.25 | 1.99 |
| OPM % | 12.32% | 19.43% | 15.36% | 11.41% | 5.91% | 16.19% | 11.14% | 16.97% | 6.14% | 20.79% |
| Other Income | 0 | 0.01 | 0.03 | 0.13 | 0.09 | 0.21 | 0.05 | 0.06 | 0.07 | 0.07 |
| Interest | 0.02 | 0.13 | 0.15 | 0.05 | 0.01 | 0.02 | 0.17 | 0.19 | 0.15 | 0.19 |
| Depreciation | 0.01 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| PBT | 0.31 | 0.85 | 0.36 | 0.45 | 0.29 | 1.28 | 0.32 | 1.1 | 0.12 | 1.82 |
| Tax % | 25.81% | 32.94% | 25% | 33.33% | 27.59% | 27.34% | 34.38% | 25.45% | 33.33% | 24.73% |
| Net Profit | 0.24 | 0.57 | 0.27 | 0.3 | 0.22 | 0.93 | 0.21 | 0.83 | 0.09 | 1.37 |
| EPS (₹) | 2.04 | 4.84 | 1.61 | 1.78 | 1.31 | 5.53 | 1.25 | 4.94 | 0.54 | 8.15 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | 13.64 |
| Expenses | 0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | 11.4 |
| Operating Profit | 0.04 | 0.46 | 1.4 | 0.97 | 1.41 | 1.78 | 2.24 |
| OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.82% | 16.42% |
| Other Income | 0 | 0 | 0.02 | 0.17 | 0.3 | 0.11 | 0.14 |
| Interest | 0 | 0 | 0.19 | 0.23 | 0.04 | 0.36 | 0.34 |
| Depreciation | 0 | 0 | 0.07 | 0.1 | 0.1 | 0.11 | 0.1 |
| PBT | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.94 |
| Tax % | 25% | 23.91% | 31.03% | 28.4% | 26.75% | 27.46% | 24.74% |
| Net Profit | 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 |
| EPS (₹) | 0.75 | 9 | 6.88 | 3.45 | 6.84 | 6.13 | 8.68 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | −0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 10.37 |
| Borrowings | 0 | 0 | 4.11 | 1.28 | 1.8 | 2.98 | 2.39 |
| Other Liabilities | 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 4.3 |
| Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.74 |
| Fixed Assets | 0 | 0 | 0.41 | 0.33 | 0.33 | 0.23 | 0.24 |
| CWIP | 0 | 0 | 0 | 0 | 0.14 | 0.14 | 0.62 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 17.88 |
| Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.74 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 0.12 | 0.03 | −4.28 | −0.79 | −1.24 | −0.49 | 1.99 |
| Investing | 0 | 0 | −0.47 | 0.02 | −0.16 | 0.02 | −0.53 |
| Financing | 0 | 0 | 4.76 | 2.81 | 0.49 | 0.82 | −0.92 |
| Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | −0.92 | 0.35 | 0.54 |
| Free Cash Flow | 0.12 | 0.03 | −4.75 | −0.81 | −1.48 | −0.5 | 1.41 |
| CFO/EBITDA | 300 | 9 | −294 | −44 | −59 | −1 | 105 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 192 | 80.42 | 322 | 300 | 287 | 330 | 317 |
| Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 | 56.54 |
| Days Payable | 350 | 128 | 162 | 105 | 143 | 97.87 | 114 |
| Cash Conversion Cycle | −74.04 | 42.32 | 246 | 286 | 194 | 299 | 260 |
| Working Capital Days | −57.63 | 25.98 | 157 | 256 | 217 | 271 | 237 |
| ROCE % | — | 219.05% | 41.54% | 13.16% | 15.3% | 14.28% | 16.28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view EP Biocomposites insights
55 extracted metrics across FY20–FY26.
Documents
- General announcements 29 Sep 2026
- General announcements 26 Sep 2026
Frequently Asked Questions about EP Biocomposites
What does EP Biocomposites Ltd do?
Where is EP Biocomposites Ltd (EPBIO) listed?
Which sector does EP Biocomposites Ltd belong to?
What is the 52-week high and low of EP Biocomposites Ltd?
What is the Return on Equity (ROE) of EP Biocomposites Ltd?
Company Information
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543595.md for EP Biocomposites Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.